Whereas the chemotactic peptide, N-formyl-L-methionyl-L-leucyl-L-phenylalanine (Met-Leu-Phe), induced NADPH-oxidase-catalyzed superoxide (0;) formation in human neutrophils, purine and pyrimidine nucleotides per se did not stimulate NADPH oxidase but enhanced 0; formation induced by submaximally and maximally stimulatory concentrations of Met-Leu-Phe up to fivefold. On the other hand, Met-Leu-Phe primed neutrophils to generate 0; upon exposure to nucleotides. At a concentration of 100 pM, purine nucleotides enhanced 0; formation in the effectiveness order adenosine 5'-0-[3-thio]triphosphate (ATP[yS]
proteins [lo-141. This was suggested by the finding that the phosphorothioate analogue of GTP, GTPIyS], enhanced 0; formation in cell-free systems severalfold and that the corresponding GDP analogue, GDP [BS] , competitively antagonized the effects of GTP [yS] [lo, 141. Similar observations with CTP [yS] and GDP [PS] have been made for several Gprotein-regulated effector systems including the regulation of phospholipase C in permeabilized cells [15-171. Under physiological and even more so under pathological conditions such as inflammation, thrombosis, hemorrhage, hypoxia and trauma, nucleotides are released into the extracellular space from a variety of cellular systems including neurones, chromaffin cells, endothelium, platelets, and damaged tissues [18 -221. Released ATP binds to purinoceptors which regulate many cell functions [19, 23] . Purinoceptors can be divided into subtypes according to the effectiveness order of purinergic agonists [19, 231 . Phosphorothioate analogues of adenine nucleotides are useful tools to study the stereospecificity of purinoceptors [24, 251 . In addition to their direct effects on G proteins [lo, both GTP[yS] and GDP [PS] prevent activation of intact platelets via competitive antagonism with ADP at purinoceptors [26, 271. In addition to ATP, UTP modulates cellular functions. UTP induces contraction or endotheliuin-dependent relaxation of blood vessels, prostacyclin formation, calcium mobilization and metabolic changes in various cell types [18, 21, 22, 28 -301 . The existence of pyrimidinoceptors as a class of nucleotide receptors was suggested by the finding that UTP was similarly effective as ATP in inducing cellular activation [18, 28, 291. Extracellular nucleotides play a role in the regulation of myeloid cells, as ATP and its phosphorothioate analogue, ATP [yS] , induce calcium mobilization in HL-60 leukemic and U-937 myelo-monocytic cells and in mouse macrophages [31, 321. In addition, nucleotides induce neutrophil aggregation [33, 341 and ATP stimulates the release of P-glucuronidase in guinea-pig neutrophils [35] . Furthermore, Kuhns et al. report- ed that ATP and UTP induced an increase in the intracellular calcium concentration and enhanced Met-Leu-Phe-induced 0; formation in human neutrophils [36] .
All these findings prompted us to study in detail regulation of neutrophil functions by extracellular nucleotides, particularly by pyrimidine nucleotides. We report that purine and pyrimidine nucleotides potentiate fMet-Leu-Phe-induced 0; formation and degranulation and per se induce aggregation in human neutrophils with similar effectiveness. Using various naturally occurring nucleotides and chemically modified derivatives, especially phosphorothioate analogues, we show that these activations are stereospecific and presumably involve nucleotide receptors and pertussis-toxin-sensitive G proteins.
MATERIALS AND METHODS

Synthesis of (Sp)-ATP(PS], (Rp)-ATP(PS], (Rp)-UTP(PS], UTP(yS] and UDP[PS]
UDP [PS] was synthesized in analogy to the method published for the synthesis of ADP [BS] [37]. UTP [yS] was prepared by incubation of GTP [yS] and UDP in the presence of nucleoside-diphosphate kinase from beef liver (Boehringer Mannheim, Mannheim, FRG) under the conditions described by Goody et al. [38] . UTP [.jS] and UDP [PS] were purified by reverse-phase HPLC using a linear gradient of 0-15% (by vol.) acetonitrile in 100 mM triethylammonium bicarbonate, pH 7.0, within 20 min. The diastereomers of ATP[PS] were prepared as described [39] . The Rp-diastereomer of UTP [PS] was synthesized accordingly. Purity of all compounds was checked by 'P-NMR-spectroscopy, showing the expected chemical shift values.
Other materials
Inorganic pyrophosphate, A23187, p-nitrophenyl p-Dglucuronide, [a,P-CH2]ATP, uridylyl (3',5')uridine and TTP were obtained from Sigma Chemie (Deisenhofen, FRG). All other nucleotides were of the highest degree of purity available and were obtained from Boehringer Mannheim (Mannheim, FRG). Stock solutions of nucleotides (10 mM) were prepared in 138 mM NaC1, aliquoted and stored at -20°C. LTB4 was a gift of Hoechst AG (Frankfurt/Main, FRG), and pertussis toxin was kindly provided by Dr. Motuyuki Yajima (Kyoto, Japan). PAF was a gift of Dr. Santosh Nigam (Abteilung fur Gynakologische Endokrinologie, Unversitatsklinikum Steglitz, Freie Universitat Berlin). Sources of other materials have been described elsewhere [lo-13, 401.
Preparation of human neutrophils
Heparinized blood was obtained by venous puncture from healthy volunteers of either sex who had taken no drugs for at least three weeks. Neutrophils were isolated by dextran sedimentation and centrifugation through Ficoll-Hypaque [lo, 11,40,41] . Cell preparations consisted of more than 98% viable neutrophils as judged by trypan blue dye exclusion.
Assay for 0;-generation NADPH-oxidase-catalyzed 0; generation was monitored by continuous measurement of ferricytochrome c reduction inhibitable by superoxide dismutase, using an Uvikon 810 dual-beam spectrophotometer (Kontron, Eching, FRG). Reaction mixtures (500 p1) contained 1-2 x lo6 neutrophils, 100 pM ferricytochrome c and a buffer consisting of 138 mM NaCl, 6 m M KCl, 1 mM MgC12. 1 mM CaC12, 1 mM Na2HP04, 5 mM NaHC03, 5.5mM glucose and 20mM Hepes, pH 7.4. Reaction mixtures were preincubated for 3 min at 37°C. 0; generation was initiated by the addition of stimuli [40] . All assays were performed in the absence of cytochalasin B. The formation of 0; was completed within 1 -12 min, depending on the stimuli used. The total amounts of 0; generated were calculated according to Markert et al. [41] , and these values are shown in the tables and figures.
Assay.for release of P-glucuronidase Neutrophils (2.5 -5 x lo6 cells) were suspended in 500 pl of the buffer described above and were incubated for 5 min at 37°C in the presence of cytochalasin B ( 5 pg/ml). Reactions were initiated by the addition of stimuli. After 10 min, reactions were terminated by placing the tubes onto melting ice. Reaction mixtures were centrifuged for 10 min at 250 x g. The determinations of P-glucuronidase and lactate dehydrogenase activities of the supernatant fluids of reaction mixtures and of cell lysates were performed as described [42] .
Aggregation of neutrophils Aggregation was measured by turbidometry [4, 8] . Neutrophils (5 x lo6) were suspended in 900 p1 of the buffer described 
RESULTS
The effects of purine and pyrimidine nucleotides on 0; formation were studied. The kinetics of 0; formation are shown in Fig. 1 [yS] were cross-desensitized as has been shown for several stimuli in neutrophils [43] .
The concentration/response curves to stimulation of fMetLeu-Phe-induced 0; formation by extracellular nucleotides are shown in pars pro toto for ATP, ATP [yS] , UTP and UTP [yS] (Fig. 2) . Nucleotides concentration-dependently enhanced Net-Leu-Phe-induced 0, formation. The effects of nucleotides were evident at concentrations above 0.3 1 M and did not reach a plateau at a concentration of 100 pM. This type of concentration/response curve has been observed for the activation of numerous cellular functions by purine and pyrimidine nucleotides [18, 24, 25, 441 . As nucleotide concentrations > 100 pM are unlikely to occur in the extracellular space in vivo [18, 19, 22, 291 , and as nucleotides at higher concentrations may permeabilize cells [45, 461 , the effects of higher concentrations of nucleotides were not investigated. In neutrophils nucleotides at concentrations of up to 100 pM did not cause cell damage as revealed by trypan blue dye exclusion (data not shown) and the release of lactate dehydrogenase (see below).
The nucleotides specificities for NADPH oxidase activation by purine and pyrimidine nucleotides were investigated. At a concentration of 100 pM, the purine nucleotides, (Rp)-ATP [PS] and [P,y-NHIATP significantly enhanced chemotactic-peptide-induced 0, formation in the effectiveness order given in Table 1. 
ADP[PS], (Sp)-ATP[aS], [a$-
CHz]GTP and GDP were inactive. In contrast, adenosine inhibited 0; formation by more than 50%, presumably via adenosine A2 receptors [47] . The pyrimidine nucleotides,
UTP[yS], (Rp)-UTP[BS], UDP[PS]
, UTP and CTP significantly enhanced met-Leu-Phe-induced 0; formation as shown in Table 1 . In contrast, uridylyl (3',5')uridine, UDP, UDP-glucose, UMP, uridine, TTP, inorganic orthophosphate and pyrophosphate as well as the coenzymes, NAD' and NADP+, were inactive. UTP[yS], (Rp)-UTP[PS], UTP and UDP [BS] but not UDP were significantly more effective potentiators of 0; formation than the corresponding adenine nucleotides.
As far as regulation of G proteins by phosphorothioate analogues is concerned, a tenfold excess of GDP [PS] antagonizes the stimulatory effects of GTP [yS] [lo, 14, 151. Therefore, we investigated the possibility that phosphorothioate analogues of nucleoside diphosphates are partial antagonists at neutrophil nucleotide receptors, i. e. that they prevent potentiation of 0; formation by phosphorothioate analogues of nucleoside triphosphates. Table 1 . Nucleotide specificity for stimulation of fMet-Leu-Phe-induced 0; formation Nucleotides (100 pM each) or solvent (control) were added to reaction mixtures simultaneously with fMet-Leu-Phe (30 nM 
(Rp)-UTP[PS]
6.5 f 1 .O 6.0 f 1.0 4.6 f 1.5 3.9 f 0.7 3.5 f 0. (Fig. 3) . UTP and UTP [yS] did not prime the cells to respond to non-stimulatory concentrations of fMet-Leu-Phe (1 -3 nM), indicating that a small but over-threshold activation of NADPH oxidase by fMet-Leu-Phe (10-30 nM) was required for synergistic interaction with UTP or UTP [yS] . The relative stimulatory effects of UTP and UTP [yS] were greater in the presence of submaximally stimulatory concentrations of fMet-Leu-Phe than in the presence of maximally stimulatory concentrations. Conversely, the absolute stimulatory effects of UTP and UTP [yS] were greater at high concentrations of Met-Leu-Phe. In the experiment shown in Fig. 3 , nucleotides lowered the ECS0 for activation of NADPH oxidase by Met-Leu-Phe from 130 nM to 60-75 nM. In two separate experiments with neutrophils of different donors UTP reduced the EC50 for NADPH oxidase activation by fMet-Leu-Phe from 60nM to 40nM and from 50 nM to 30 nM (data not shown). A similar range of interindividual variation of the EC50 for NADPH oxidase activation by fMet-Leu-Phe has been reported by Simpkins et al. [48] . In analogy to UTP and UTP [yS] , ATP and ATP[yS] also lowered the ECS0 for fMet-Leu-Phe (data not shown).
In addition to fMet-Leu-Phe, PAF and LTB4 are wellknown activators of neutrophils [l -3, 51. Therefore, we studied the interactions of various stimuli on 0; formation (Table 3). In preliminary experiments, the concentration of PAF and LTB4 used in the present study (300 nM for each) was found to be maximally effective to activate 0; formation. In agreement with previous results, we found that PAF and LTB4 at maximally stimulatory concentrations activated 0; formation much less effectively than fMet-Leu-Phe, even when the latter agonist was present only at a submaximally stimulatory concentration (30 nM) [2, 31. In addition, the activations of NADPH oxidase by PAF and LTB4 were very brief and lasted less than 3 min. These differences in the capacities of the intercellular signal molecules to activate NADPH oxidase may be explained by the fact that in contrast to Met-LeuPhe, PAF and LTB4 lead only to a transient generation of polyphosphoinositol-lipid-derived second messengers, the concentrations of which may be insufficient for a prolonged activation of NADPH oxidase [49 -511. fMet-Leu-Phe plus PAF synergistically activated NADPH oxidase to a similar extent as did fMet-Leu-Phe plus UTP [yS] . The combination of fMet-Leu-Phe plus LTB4 resulted in a less pronounced synergistic activation of NADPH oxidase [2] . Interestingly, the combination of PAF plus LTB4 was as effective in inducing 0; formation as was fMet-Leu-Phe plus LTB4. In contrast, UTP[yS] caused only a small but significant enhancement of PAF-or LTB,-induced 0; formation. Essentially the same results were obtained with ATP[yS] (data not shown).
The effects of nucleotides on degranulation in human neutrophils were studied. Similarly to activation of NADPH oxidase, UTP[yS] and ATP [yS] (data only shown for ATP[yS]) per se did not induce the release of P-glucuronidase (Fig. 4) . At a maximally stimulatory concentration (1 pM), fMet-LeuPhe induced the release of 40 & 5% (mean SEM, n = 11) of cellular P-glucuronidase. The release of P-glucuronidase from neutrophils in the presence of cytochalasin B ( 5 pg/ml) and in the absence of agonists amounted to 6% of cellular content and paralleled the release of lactate dehydrogenase. In the presence of met-Leu-Phe at a submaximally stimulatory concentration (10 nM), the release of P-glucuronidase amounted to 12% of the cellular content. The effect of M e tLeu-Phe was enhanced by ATP [yS] and UTP[yS] at concentrations above 1 FM without an increase in the release of lactate dehydrogenase. This specificity of nucleotides for the 
analogues of nucleoside diphosphutes ( N D P [ a S ] ) and nucleoside triphosphutes ( N T P [ y S ] ) on fMet-
. . . release of /&?I ucuronidase demonstrates that nucleotides did not increasc (he plasma membrane permeability. As was the case for potentiation of Met-Leu-Phe-induced 0; formation, the concentration/response curves to nucleotides for degranulation did not reach saturation at 100 pM. The nucleotide specificities for degranulation were similar to those for 0; formation, but the differences in the effectiveness of nucleotides were less marked (Table 4) Finally, we investigated the effects of nucleotides on aggregation of human neutrophils. Typical superimposed aggregation traces are shown (Fig. 5) . UTP per se induced aggregation, reaching a maximum at a concentration of 100 pM. Both V,,, and the maximum extent of aggregation depended on the nucleotide Concentration. The extent of aggregation induced by UTP (100 pM) amounted to 48% of that induced by a maximally stimulatory concentration of Wet-Leu-Phe (1 pM). Aggregation induced by UTP followed similar kinetics as that induced by the chemotactic peptide and was irreversible. In addition, UTP synergistically enhanced aggregation induced by a submaximally stimulatory concentration of Met-Leu-Phe. At a concentration of 10 mM, fMet-LeuPhe induced aggregation to an extent amounting to 34% of that of Met-Leu-Phe at a concentration of 1 pM. UTP concentration-dependently enhanced aggregation induced by fMet-Leu-Phe (10 nM) up to the same extent as Met-LeuPhe at a maximally stimulatory concentration. The nucleotide The role of pertussis toxin-sensitive G proteins in the activation of neutrophils by extracellular nucleotides was studied. In agreement with previous results [6] we found that treatment of neutrophils with pertussis toxin at a concentration of 1 pg/ml for 3 h completely prevented Met-LeuPhe-induced 0; formation. In addition, pertussis-toxintreated cells did not generate 0; upon exposure to met-LeuPhe plus ATP [yS] or UTP[yS] (data not shown). Using these conditions of treatment pertussis toxin almost completely inhibited aggregation by Net-Leu-Phe, ATP and UTP but not aggregation induced by the calcium ionophore, A231 87, which circumvents receptor-stimulation by directly increasing the intracellular calcium concentration (Fig. 6) . These results indicate that both the effects of met-Leu-Phe and of extracellular nucleotides are mediated via G proteins.
Leu-Phe-induced
0; generation Nucleotides or solvenl (control) were added to reaction mixtures simultaneously with Met-Leu-Phe (30 nM
DISCUSSION
In addition to purine nucleotides, extracellular pyrimidine nucleotides are known to activate various cellular functions with similar effectiveness as purine nucleotides [18, 22, 28 -30, 331 . Whereas much work has been performed to elucidate the mechanism by which purine nucleotides mediate their effects, much less attention has been paid to the effects of pyrimidine nucleotides. As ATP and UTP are known to induce aggregation and calcium mobilization in white blood cells [31-341, we investigated human neutrophils as a model system for purinergic and pyrimidinergic cell activation. Due to the low potency of nucleotides and the presence of ectonucleotidase activity in the plasma membrane of neutrophils [52] , binding studies with nucleotides are difficult to perform. Therefore, nucleotide receptors in neutrophils at present can only be assessed by measuring cell functions, as is the case for most other nucleotide-regulated cell systems 119, 231. We measured 0, formation, release of B-glucuronidase and aggregation as parameters of neutrophil activation. We found that extracellular nucleotides activated neutrophils at concentrations between 0.1 -100 pM. As the concentration of ATP has been shown to reach 20 pM in the systemic circulation after tissue injury [19] , neutrophil activation by extracellular nucleotides obviously is of physiological relevance. The fact that nucleotides per se lead only to aggregation but not to activation of 0, formation and degranulation suggests that stimulations of these functions require different signal transduction pathways. In addition, activations of 0; formation and degranulation appear not to be prerequisites for induction of aggregation. Several findings suggest that purine and pyrimidine nucleotides act via plasma membrane receptors. Most importantly, nucleotide-induced aggregation of neutrophils in pertussis-toxin-sensitive (see Fig. 6 ), suggesting that nucleotide receptors interact with G proteins. Interaction of purinoceptors with pertussis-toxin-sensitive G proteins has also been shown for inhibition of adenylyl cyclase in liver [53] . In addition, the desensitization of cell responses to nucleotides is a typical characteristic of receptor-mediated processes [43] . Furthermore, the stereospecificity of neutrophil activation by purine and pyrimidine nucleotides points to the recognition of nucleotides by specific receptors.
ATP, GTP and ITP are similarly effective agonists at neutrophil purinoceptors. In addition, neutrophil purinoceptors stereoselectively discriminate between phosphoro- thioate analogues of ATP and ADP (see Table I ). In contrast, purinoceptors in smooth muscle cells do not show stereoselectivity for the diastereomers of ATP [pS] , and both (Sp)-ATP[aS] and ADP [PS] are effective agonists at these receptors [24, 251. In platelets, ADP is the most potent agonist, and in mast cells only ATP acts as an agonist at purinoceptors [19, 54] . In addition, GDP [pS] , GTP [yS] and ATP are competitive antagonists at platelet purinoceptors but agonists at neutrophil purinoceptors [26, 271. Furthermore, ] -ATP and [P,y-CH2]ATP are Pzx-purinoceptor agonists but not activators of human neutrophils [19, 231. Finally, ATP[yS] is a less effective agonist at P,,-purinoceptors than ATP but not at neutrophil purinoceptors [44] . These data suggest that neutrophil purinoceptors are different from purinoceptors in other cell types. ATP, GTP, ITP and ADP may represent the endogenous ligands for neutrophil purinoceptors. As pyrimidine nucleotides also stimulate neutrophils, the question arises whether pyrimidine nucleotides mediate their effects via purinoceptors or via distinct pyrimidinoceptors, the existence of which has been suggested in recent studies [18, 28, 291 . Uracil nucleotides are similarly effective stimulators of 0; formation, aggregation and degranulation as their corresponding adenine analogues (see Tables 1, 4 and 5). Whereas ATP, GTP and ITP are simiIarly effective activators of neutrophils, activation by pyrimidine nucleotides exhibits base specificity. UTP is more effective than CTP, and TTP is totally inactive. These results indicate that neutrophil nucleotide receptors do not only recognize the triphosphate but also the base of pyrimidine nucleotides. In addition, there is no stereochemical similarity between purine and pyrimidine nucleotides. The cross-desensitization between purine and pyrimidine nucleotides does not necessarily imply that purine and pyrimidine nucleotides act via the same receptor, as crossdesensitization between different receptors in neutrophils has been reported before [43] . We observed synergistic interaction of phosphorothioate analogues of purine and pyrimidine nucleotides on 0 2 formation (see Table 2 ). Synergism between signal transduction pathways activated by different receptors is a well-known phenomenon in neutrophils (see Table 3 ) [2, 51 and may also be true for purino-and pyrimidinoceptors. Considering the functional similarities between purine and pyrimidine nucleotides, it appears likely that pyrimidinoceptors represent a class of nucleotide receptors functionally related to purinoceptors. Finally, UTP appears to be the endogenous ligand for these putative pyrimidinoceptors.
The nucleotide effects are not specific for the triphosphates. Among the phosphorothioate analogues of nucleoside diphosphates, GDP [PS] and UDP [PS] are similarly active as the corresponding triphosphates with respect to 0, formation and degranulation (see Tables 1 and 4 diphosphates. As phosphorothioate analogues of nucleoside diphosphates are extremely poor substrates for nucleosidediphosphate kinases and adenylate kinase 115, 381, it is unlikely that these nucleotides act as their corresponding triphosphates. In addition, the transphosphorylation-resistant analogue of ATP, [P, , caused a small but significant stimulation of 0, formation. Therefore, we conclude that purino-and pyrimidinoceptors recognize tri-as well as diphosphates.
As far as the effects of phosphorothioate analogues on 0; formation in intact neutrophils are concerned, our results suggest that these effects are mediated via purinoceptors and not directly via G proteins. First, nucleotides are hydrophilic molecules which do not sufficiently cross the plasma membrane [16, 17, 26, 271 . This reaction is time-dependent, but stimulation of 0; formation by extracellular nucleotides is rapid in onset without a significant lag time (see Fig. 1 ). In addition, GDP [PS] and UDP [PS] are activators of 0, formation in intact cells but no thiophosphoryl group donors in kinase-mediated reactions. Our results are in agreement with recent studies demonstrating that phosphorothioate analogues of nucleoside diphosphates and triphosphates act in the same direction at nucleotide receptors [24, 251. There are certain functional similarities between nucleotides, PAF and LTB4. In analogy to nucleotides, PAF and LTB4 bind to specific recpetors and via G proteins activate neutrophils [5] . In agreement with previous results we found that PAF and LTB4 are less effective activators of 0, forrnation than met-Leu-Phe [2, 31, while nucleotides per se are totally inactive (see Table 3 ). However, cells that have been stimulated with a low concentration of the chemotactic peptide become responsive to nucleotides. This activation of NADPH oxidase by nucleotides is small and short-lasting, similarly to activations of 0; formation by PAF and LTB4 [2] . Nucleotides, PAF and LTB4 synergistically enhance m e tLeu-Phe-induced 0, formation, suggesting that their physiological function is to potentiate 0; formation induced by chemotactic peptides rather than to activate NADPH oxidase per se. This interpretation is also supported by the finding that combinations of PAF or LTB4 plus nucleotides result only in small enhancements of 0; formation. In contrast, the combinations of Wet-Leu-Phe plus PAF or LTB4 or nucleotides result in very marked synergism. However, the combination of PAF plus LTB4 shows more pronounced synergistic activation of 0, formation than the combinations of lipid mediators with nucleotides. These data indicate that PAF and LTB4 on one hand and nucleotides on the other hand are functionally related but not equivalent neutrophil activators.
Nucleotides potentiate chemotactic-peptide-induced 0; formation and P-glucuronidase release even with both classes of stimuli present at high concentrations, indicating that these agents induce neutrophil activation via different mechanisms. Agonists acting via distinct receptors may additively activate G proteins and thus may amplify activation of effector systems, i.e. NADPH oxidase and/or phospholipase C, finally leading to 0, formation, aggregation and degranulation. In addition, occupation of nucleotide receptors with agonists may increase the number and/or affinity state of formyl peptide receptors as is suggested by the nucleotide-induced reduction of the ECSo for NADPH oxidase activation by Wet-Leu-Phe. The relatively small synergistic activation of 0; formation by nucleotides plus lipid mediators in comparison to the combination of nucleotides plus Wet-Leu-Phe may be due to the fact that the former combinations lead only a small amplification of activation of signal transduction components. This interpretation is also supported by the fact that PAF and LTB4 lead only to transient activation of phospholipase C [49 - 511, as may also be true for nucleotides.
In summary, we present evidence that nucleotides which are released into the extracellular space under various physiological and pathological conditions may play roles as intercellular signal molecules in the activation of neutrophils. Taking into consideration the fact that extracellular nucleotides do not only activate neutrophils but also endothelium, smooth muscle cells, platelets, mast cells and lymphocytes, these agents may act simultaneously and in a coordinated way to regulate multiple functions of various cell types, which are located close together in vivo. Phosphorothioate analogues of purine and pyrimidine nucleotides are useful experimental tools to study nucleotide receptors in neutrophils. Finally, the development of competitive antagonists for neutrophil nucleotide receptors may be an interesting approach to interfere with inflammatory processes as has already been shown for PAF antagonists [55] .
